🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Super proud of our brilliant medical oncology fellow Melissa Lumish MD and her Tow Center for Developmental Oncology Career Development Award recognizing her work studying the microbiome in #youngonset gastrointestinal cancers Andrea Cercek Yelena Y. Janjigian MD @ldiaz1 MSKCC's Center for Young Onset Colorectal Cancer

Grateful for our incredible team Luis Diaz, Melissa Lumish MD, Jenna, and Jill Weiss! ASCO #ASCO22 Memorial Sloan Kettering Cancer Center 

With super stars ⭐️⭐️ In #NYC Memorial Sloan Kettering Cancer Center waking up to messages & congrats calls from all over 🌎 on how absolutely amazing our GI Oncology group is 🥰MSK Department of Medicine privileged to have Luis Diaz Andrea Cercek Melissa Lumish MD as colleagues plus 43 gifted GI MDs. #teamwork

Grateful to Stand Up To Cancer for sharing the inspirational stories of patients who’ve benefitted from advances in cancer research including Kelly, who participated in a Memorial Sloan Kettering Cancer Center rectal cancer clinical trial led by physician-scientist Dr. Luis Diaz & oncologist Dr. Andrea Cercek.

So excited to share our data on #LynchSyndrome and risk of new neoplasia after immunotherapy Thank you to our terrific colleagues Emily Harrold Mike Foote @BenjcRousseau Luis Diaz and many others MSK Department of Medicine

An analysis of published studies suggests that a longer duration of immune checkpoint inhibitor therapy is associated with a higher incidence of complete response among patients with mismatch repair–deficient cancers. Full correspondence: nej.md/3EXiEpe

Congratulations to our team. Next chapter in Nonoperative Management of Mismatch Repair–Deficient Tumors | New England Journal of Medicine nejm.org/doi/10.1056/NE…